The PLAU gene gives your body instructions for making a protein that helps dissolve blood clots and supports wound healing by clearing away extra material around cells. This gene plays an important role in how tissues repair and remodel after injury. When the PLAU gene is not working normally, clot breakdown can become unbalanced, which may contribute to bleeding problems or slower tissue repair, depending on the variant. Some changes in this gene are linked to rare inherited bleeding conditions.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do the work. Others mainly help determine when certain processes happen, where they take place, and how strongly they run. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
PLAUGene function
What if the gene works
Your cells use the PLAU gene to make a protein that helps dissolve blood clots and clear damaged material. It also supports wound healing and normal tissue remodeling as cells move and repair.
Risk
What if the gene does not work
Some variants in the PLAU gene can disturb clot breakdown and are linked to Quebec platelet disorder, with delayed bleeding after injury or surgery. Milder and more severe variants can influence when bleeding appears and how pronounced it is.
Treatment
What does that mean for your treatment
In PLAU-related Quebec platelet disorder, antifibrinolytic medicines such as tranexamic acid can be especially helpful for bleeding episodes and around surgery. This gene finding may steer care away from relying only on platelet transfusions, because excess clot breakdown is a key treatment target.
Conditions associated with PLAU
Gene function
What if the gene works
Your body uses the PLAU gene during everyday repair and cleanup. It helps make a protein that switches on plasmin, an enzyme that breaks down fibrin, the mesh that forms in blood clots. This helps explain how the PLAU gene supports wound healing and normal tissue repair.
PLAU helps turn plasminogen into plasmin, an enzyme that cuts through fibrin and some other proteins outside cells. This starts a controlled cleanup process in tissues.
By helping remove fibrin, the PLAU gene supports the normal breakdown of a clot after bleeding is controlled. This keeps healing moving forward in an orderly way.
PLAU activity helps clear and reshape the material around cells during routine repair. This gives tissues room to renew and adjust their structure.
The protein from this gene works near the cell surface so its activity happens where it is needed. This supports normal cell movement during healing and other everyday tissue processes.
What is a variant?
A genetic variant is a slight alteration in the DNA sequence of a gene. Variants are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many do not produce any noticeable effect and simply represent natural genetic variation. At times, though, a variant can change gene function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PLAU gene can change how much of its protein is made. They can also alter how well the protein is folded, activated, or able to interact with nearby molecules. This is how changes in the PLAU gene affect protein activity: some variants have mild effects, while more disruptive variants can markedly reduce function or, in some cases, increase production.
How variants are linked to conditions
Certain inherited variants in the PLAU gene cause Quebec platelet disorder, a rare bleeding condition. In PLAU gene variants and Quebec platelet disorder, the clearest link is a higher chance of delayed bleeding, often after surgery, dental work, injury, or childbirth. Other reported PLAU gene associations in common diseases have not reached the same level of clinical certainty.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and occur widely in the general population. Most do not have a direct effect on health and instead represent normal human diversity. For many genes, carrying a variant tied to a condition suggests a possible association, not a definitive diagnosis, particularly when several genes and environmental factors are also involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a harmful PLAU change, bleeding risk is mostly driven by the variant itself. Bleeding is more likely with surgery, dental work, injuries, childbirth, and sometimes with medicines that affect clotting, such as aspirin, ibuprofen, or blood thinners. Planning ahead for procedures can help lower the chance of serious bleeding problems.
Inheritance of PLAU variants
For families asking how PLAU gene variants are inherited, the best established pattern is autosomal dominant for PLAU-related Quebec platelet disorder. This means a parent carrying the disease-causing variant can pass it to a child of any sex, and each pregnancy has a 50% chance of inheriting that variant. A person only needs one altered copy of the PLAU gene to have this inherited bleeding condition. Fathers and mothers can both pass it on to sons or daughters.
What does my PLAU result mean for my family?
For PLAU, the best-known inherited family pattern is linked to Quebec platelet condition, a rare bleeding condition that usually runs in families in a dominant way. This means close relatives, such as a parent, sibling, or child, may also carry the same PLAU change and could have easy bruising, nosebleeds, or bleeding after surgery or dental work. Family testing can help clarify who else in the family may be affected.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the PLAU gene, doctors use genetic testing for PLAU variants, usually from a blood sample or saliva. A lab reads the DNA code in the PLAU gene and compares it with the usual sequence to see whether a variant is present.
When should I consider getting a genetic test?
Genetic testing for the PLAU gene may be worth considering if you or close relatives have a rare inherited bleeding problem, especially delayed bleeding after surgery, dental work, or childbirth, or easy bruising despite normal routine blood tests. It can help confirm a rare bleeding condition called Quebec platelet disorder when symptoms or family history point in that direction.
A genetic result is only one part of your health story
A genetic result may provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Many factors shape how the body functions over time, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information adds context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results may help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work well for one person but less well for another. These differences are common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
The field of pharmacogenetics examines how differences in genes affect the way people respond to medicines. It studies gene-drug patterns to help explain why the same treatment can work differently in different people. With many medications, genes can influence both how strongly a medicine works and how the body handles it. This information can support more informed, personalized treatment decisions. To explore this topic in more detail, you can find additional information in the LearnHub.
Drugs influenced by the PLAU gene
When should I seek medical advice?
There is not yet a widely accepted role for this gene in guiding how medicines are chosen or used. Questions about side effects, treatment changes, or how well a medicine is working are best discussed with your doctor. Research on the PLAU gene has looked at clot-busting medicines and other treatments that affect the body’s system for breaking down blood clots, but this has not become routine care.
History
Researchers first identified urokinase, the protein made from the PLAU gene, in human urine in the mid 20th century while studying how the body dissolves blood clots. This linked the PLAU gene to an important medical question long before modern DNA tools were available. Initially understood only through visible traits, later recognized as tied to a specific gene, its story reflects the shift from protein chemistry to molecular genetics. Building on this early work, scientists cloned the PLAU gene in the 1980s and began mapping how its activity changes in cancer and other conditions. Those studies helped make the PLAU gene part of broader research on tumor spread, tissue repair, and clot breakdown. Over time, descriptions became more precise as laboratory methods improved.